Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular Analgesia vs Adductor Canal Block in Knee Arthroscopy
NCT05004506Phase 3Unknown
- Sponsor
- Loyola University Chicago
- Start
- Apr 2016
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Loyola University Chicago. Primary endpoints: Analgesic efficacy (VAS scores) at 48 hours, Rescue narcotics use and 1 more. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05004506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05004506.